Short-Term Fasting During Ovarian Cancer Chemotherapy May Improve Response

A small randomized ASCO 2026 study suggests carefully supervised short-term fasting around chemotherapy may lower insulin levels and improve treatment response in advanced ovarian cancer.

A small Italian randomized trial found that patients with advanced high-grade serous ovarian cancer who followed a short-term fasting protocol during neoadjuvant chemotherapy had lower insulin levels, higher pathologic complete response rates, and longer median progression-free survival compared with patients who continued a regular diet. The results ar…